Interpace Diagnostics (IDXG) Reports Q3 Loss of $0.11, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (AMEX: IDXG) | Delayed: 6.50 +1.10 (20.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.40 | 52 Week High | $0.64 | |||
| Open | $5.80 | 52 Week Low | $0.10 | |||
| Day High | $6.50 | P/E | N/A | |||
| Day Low | $5.80 | EPS | $0.00 | |||
| Volume | 2,753 | |||||
